proposed that targeting STAT3 can inhibit tumor growth through downregulating Bcl‐xL expression to increase apoptosis of HNSCC cancer cells, which supports the view of STAT3 as an oncogene.45 The gene discussed is BCL2L1; the disease is neoplasm.